Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
258 Leser
Artikel bewerten:
(1)

Veterinary Vaccines Market worth $18.46 billion by 2031 | MarketsandMarkets

DELRAY BEACH, Fla., Jan. 19, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Veterinary Vaccines Market is projected to grow from about USD 13.02 billion in 2026 to USD 18.46 billion by 2031, at a CAGR of 7.2%.

MarketsandMarkets Logo

Browse 302 market data Tables and 60 Figures spread through 450 Pages and in-depth TOC on "Veterinary Vaccines Market- Global Forecast to 2031"

Veterinary Vaccines Market Size & Forecast:

  • Market Size Available for Years: 2025-2031
  • 2026 Market Size: USD 13.02 billion
  • 2031 Projected Market Size: USD 18.46 billion
  • CAGR (2026-2031): 7.2%

Veterinary Vaccines Market Trends & Insights:

  • Based on type, the livestock vaccines segment accounted for the largest share of 28.6%.
  • By disease, the livestock vaccines segment accounted for the largest share of 31.4% in 2025.
  • Asia Pacific is the fastest-growing market for veterinary vaccines during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1233

The veterinary vaccines market is experiencing significant growth, which can primarily be attributed to the growth in the companion animal population, growing pet ownership, rising incidence of zoonotic diseases, and initiatives by government agencies to improve animal health. On the other hand, the high cost associated with vaccines is expected to restrain the growth of this market to a certain extent. Navigating these drivers and restraints will be crucial for the future development and adoption of veterinary vaccine solutions.

By type, the companion animal vaccines segment is expected to register the highest growth rate in the global veterinary vaccines market.

The companion animal vaccines market is growing significantly, driven by increasing pet ownership, heightened awareness of preventive healthcare, and the development of more effective and safer vaccines. As pets are increasingly viewed as family members, the demand for vaccinations to protect them from infectious diseases is rising. The growing recognition of zoonotic disease risks, government regulations, and the rise of pet insurance are further boosting vaccine demand. Additionally, emerging markets, particularly in Asia Pacific, are contributing to this growth as disposable incomes rise and more pet owners seek veterinary care.

Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=1233

By application, the veterinary hospitals segment is anticipated to grow at a significant rate in the veterinary vaccines market during the forecast period.

The veterinary hospitals segment is growing quickly as more pet owners seek professional care for their pets. With pets being treated like family, owners turn to veterinary hospitals for vaccinations and overall health care. These hospitals offer advanced vaccines and follow-up care, making them a go-to choose for ensuring pets stay healthy. Partnerships with pharmaceutical companies and the growing focus on preventive care are also helping drive this growth. As a result, veterinary hospitals are becoming an increasingly important part of the pet healthcare landscape.

The Asia Pacific market is expected to register the highest growth rate during the forecast period.

The veterinary vaccines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is experiencing rapid growth in the veterinary vaccines market, driven by rising pet ownership, increasing awareness of pet health, and growing disposable incomes. As more people in countries like China, India, and Southeast Asia adopt pets, there is a rising demand for veterinary care, including vaccinations. The expansion of veterinary hospitals, along with government initiatives to improve animal health and prevent zoonotic diseases, is further boosting vaccine adoption. This combination of factors makes Asia Pacific one of the fastest-growing regions in the veterinary vaccines market.

Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=1233

Top Companies in Veterinary Vaccines Market:

The Top Companies in Veterinary Vaccines Market include Zoetis (US), Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco (US), Virbac (France), Ceva (France), Phibro Animal Health Corporation (US), Hester Biosciences Limited (India), Neogen Corporation (US), HIPRA (Spain), and Biogénesis Bagó (Argentina), among others.

Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting

Related Reports:

Vaccine Adjuvants Market - Global Forecast to 2029

Veterinary Diagnostics Market - Global Forecast to 2030

Veterinary Imaging Market - Global Forecast to 2029

Allergy Diagnostics Market - Global Forecast to 2029

Veterinary Reference Laboratory Market - Global Forecast to 2030

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/veterinary-vaccines-market-worth-18-46-billion-by-2031--marketsandmarkets-302664345.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.